Phibro Animal Health (PAHC) Net Income towards Common Stockholders (2012 - 2026)

Phibro Animal Health's Net Income towards Common Stockholders history runs 15 years deep, the most recent figure standing at $24.0 million for Q1 2026.

• On a quarterly basis, Net Income towards Common Stockholders rose 15.06% year-over-year to $24.0 million in Q1 2026; TTM through Mar 2026 was $95.2 million, a 783.22% increase from a year earlier, with the FY2025 full-year figure at $48.3 million, up 211.43% from the prior year.
• Net Income towards Common Stockholders eased to $24.0 million in Q1 2026 per PAHC's latest filing, from $27.5 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $27.5 million in Q4 2025 and bottomed at -$45.0 million in Q2 2024.
• The 5-year median for Net Income towards Common Stockholders is $8.4 million (2024), against an average of $8.3 million.
• Across the five-year window, Net Income towards Common Stockholders tumbled 491.19% in 2024 and surged 762.14% in 2025, its largest moves.
• Year by year, Net Income towards Common Stockholders stood at $7.2 million in 2022, then sank by 82.33% to $1.3 million in 2023, then jumped by 150.0% to $3.2 million in 2024, then soared by 762.14% to $27.5 million in 2025, then fell by 12.51% to $24.0 million in 2026.
• Per Business Quant, the three latest PAHC Net Income towards Common Stockholders figures stand at $24.0 million (Q1 2026), $27.5 million (Q4 2025), and $26.5 million (Q3 2025).